Zinc Sulfate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ZINC CHLORIDE IN PLASTIC CONTAINER | — | 1986-06-26 | fda.gov ↗ |
Trials 123 · started per year
Also used as a comparator or background therapy in 40 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06588036 Comparator | Sep → Dec 2024 overdue | — | Combined Military Hospital Multan | Not yet recruiting | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT05670444 Comparator | Jan → Feb 2023 | influenza | Hôpital Universitaire Sahloul | Completed | No outcome recorded |
| Phase 1 | NCT05104424 Comparator | Dec 2021 → Aug 2022 | olfactory nerve disorder, oral sensibility, disturbance of | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 1 | NCT00325572 Comparator | Nov 2006 → Dec 2010 | autism spectrum disorder | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT05453227 Comparator | Dec 2021 → Dec 2022 | — | Egymedicalpedia | Completed | No outcome recorded |
| Phase 1/2 | NCT04472585 Comparator | Nov 2020 → Aug 2021 | COVID-19 | Sohaib Ashraf | Unknown | No outcome recorded |
| Phase 1/2 | NCT04591600 Background | Jul → Sep 2020 | COVID-19 | Alkarkh Health Directorate-Baghdad | Completed | No outcome recorded |
| Phase 1/2 | NCT01062009 Comparator | Nov 2008 → Oct 2014 | — | UCSF Benioff Children's Hospital Oakland | Completed | No outcome recorded |
| Phase 28 trials | ||||||
| Phase 2 | NCT07145268 Comparator | Sep 2025 → Sep 2026 expected | fibrotic liver disease, hepatitis B virus infection | Tanta University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT05398965 Background | Nov 2020 → Jan 2021 | COVID-19 | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04072822 Comparator | Jul 2020 → May 2022 | alcoholic hepatitis | Indiana University | Completed | No outcome recorded |
| Phase 2 | NCT05366595 Comparator | Jul 2019 → Jun 2022 | — | Mansoura University | Completed | No outcome recorded |
| Phase 2 | NCT03135522 Comparator | Feb 2018 → Dec 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT02058212 Comparator | Mar → Oct 2013 | endometriosis | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT01210014 Comparator | Apr 2008 → Apr 2009 | aphthous stomatitis | Qazvin University Of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00210470 Background | Jul 2005 → Dec 2010 | head and neck squamous cell carcinoma | Brooklyn ImmunoTherapeutics, LLC | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05463484 Comparator | Jul 2021 → Feb 2023 | mouth disorder | Mucosa Innovations, S.L. | Completed | No outcome recorded |
| Phase 310 trials | ||||||
| Phase 3 | NCT07275827 Comparator | Feb → Apr 2026 overdue | Helicobacter pylori infectious disease | Tanta University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05465434 Comparator | Aug 2022 → Jan 2023 | chronic hepatitis C virus infection | Tanta University | Completed | No outcome recorded |
| Phase 3 | NCT05047523 Comparator | Sep 2021 → Jun 2023 | Wilson disease | Alexion Pharmaceuticals, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT04189367 Background | Jun 2020 → Jul 2022 | burning mouth syndrome | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04810728 Background | Jun → Dec 2020 | COVID-19 | Baiturrahmah University | Completed | No outcome recorded |
| Phase 3 | NCT04377646 Comparator | May 2020 | COVID-19 | Military Hospital of Tunis | Unknown | No outcome recorded |
| Phase 3 | NCT03158168 Comparator | Mar 2018 → Jun 2019 | skin disorder caused by infection | Assiut University | Unknown | No outcome recorded |
| Phase 3 | NCT03403205 Comparator | Feb 2018 → Jun 2023 | Wilson disease | Alexion Pharmaceuticals, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT03851055 Comparator | Aug 2017 → Jul 2018 | beta-thalassemia major | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT02714543 Comparator | Nov 2013 → Aug 2015 | oral submucous fibrosis | The Oxford Dental College, Hospital and Research Center, Bangalore, India | Completed | No outcome recorded |
| Phase 46 trials | ||||||
| Phase 4 | NCT05677126 Comparator | Aug 2024 | — | American Regent, Inc. | Withdrawn | No outcome recorded |
| Phase 4 | NCT06151392 Comparator | Jul 2023 → Dec 2025 overdue | infectious disorder of the nervous system | Ain Shams University | Recruiting | No outcome recorded |
| Phase 4 | NCT04050488 Comparator | Aug 2019 → Jul 2020 | bronchopulmonary dysplasia, fetal growth restriction, necrotizing enterocolitis, neonatal sepsis +1 | Faculty of Medicine, University of Indonesia | Unknown | No outcome recorded |
| Phase 4 | NCT03005496 Comparator | Jan → Apr 2017 | — | Indonesia University | Completed | No outcome recorded |
| Phase 4 | NCT01571856 Comparator | Jul 2011 → Jul 2012 | acute diarrhea, gastroenteritis | Centro Pediatrico Albina de Patino | Completed | No outcome recorded |
| Phase 4 | NCT00431691 Comparator | Sep 2006 → Dec 2007 | escherichia coli infection, retinal disorder | Medical University of Vienna | Completed | No outcome recorded |
| Phase not applicable7 trials | ||||||
| — | NCT06009744 Comparator | Aug 2023 → Dec 2028 expected | intestinal fistula | Hospital Juarez de Mexico | Recruiting | No outcome recorded |
| — | NCT06540209 Background | Apr → Sep 2023 | acute diarrhea | RESnTEC, Institute of Research | Completed | No outcome recorded |
| — | NCT05930002 Comparator | Jul 2021 → Sep 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| — | NCT04482296 Comparator | Sep 2019 → Jul 2020 | major depressive disorder | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| — | NCT00914576 Comparator | Apr 2011 → Jul 2013 | — | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT01101217 Comparator | Feb → Sep 2009 | end stage renal failure | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| — | NCT00682955 Comparator | Aug 2007 → Apr 2008 | acute diarrhea | Aga Khan University | Completed | No outcome recorded |
Evidence & citations 18 cited values
Every value below carries the sentence it was read from. 167 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zinc sulfate | “The intervention was delivered most commonly in the form of syrup as zinc sulfate, and the most common dose was between 10 mg and 15 mg daily.” PMID 36994923 ↗ Mar 202339“The intervention was delivered most commonly in the form of syrup as zinc sulfate, and the most common dose was between 10 mg and 15 mg daily.” PMID 36994923 ↗ Mar 2023 “daily zinc sulfate (20 mg/day) for two weeks prior to immunization and until the last follow-up for sample collection” NCT01019083 ↗ “50 mg/day of zinc sulfate in addition to the standard direct-acting antiviral therapy for the same duration.” PMID 39789197 ↗ Jan 2025 “Zinc Sulfate (Zn SO4) one tablet daily at bedtime which provides 50 mg elemental zinc (220 mg Zn SO4)” NCT01474486 ↗ “Zinc Sulfate Tablets” NCT03293641 ↗ |
| Known as | Galzin (zinc acetata, Teva Pharmaceuticals) | “Galzin (zinc acetata, Teva Pharmaceuticals)” NCT00696410 ↗ |
| Known as | NPC-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321865 ↗ |
| Known as | Solvazinc | “Zinc sulphate 125mg (1 Solvazinc tablet) once daily orally after dissolution in water, day 2 to day 15” NCT01475227 ↗ |
| Known as | Zinc | “This standard treatment is personalized according to the severity but is not limited to standard antiviral therapy, azithromycin 500 mg a day, vitamin C 500 mg 8 hourly a day,...” NCT05398965 ↗97“food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗ “Depending on the site/region, participants randomized to receive Standard of Care treatment will receive trientine, penicillamine, zinc, or a combination of these medicines,...” NCT05047523 ↗ “a Cyclo-Z capsule containing Cyclo-His Pro (CHP) 0 (placebo), 3 mg (minimally effective), 9 mg (optimally effective), or 15 mg (no-additional effect) plus 20 mg zinc on...” NCT00878605 ↗ “Depending on the site/region, participants randomized to receive SoC treatment will receive trientine, penicillamine, Zinc, or a combination of these medicines, administered...” NCT03403205 ↗ “Tablet: Vitamin C, 500 mg; Vitamin D3, 1000 IU; Vitamin E, 400 IU; Folic Acid 1000 mcg; Zinc, 20 mg; Selenium 200 mcg; Lycopene, 10 mg; Capsule: Vitamin D3, 1000 IU,...” NCT02421887 ↗ “The second therapeutic arm investigates a combination antioxidant therapy (selenium 300 µg, zinc 40 mg, lycopene 45 mg and vitamin C 1.5 g), administered for 10 days.” PMID 40754325 ↗ Aug 2025 “(1 mg copper, 20 mg zinc, 180 mg vitamin C, 30 mg vitamin E, 1 mg zeaxanthin, 4 mg astaxanthin, 10 mg lutein) daily of oral, all of them in one Tablet for 24 weeks” NCT02062034 ↗ “The treatment group received two pills in the morning containing Vit C Vit D zinc and minerals and one pill of 2 mg of melatonin in the evening” NCT05670444 ↗ “Nutritional supplement: vitamin B12, folic acid, iron, zinc, vitamin B complex depending on the hematic deficiency, for 12 weeks” NCT04189367 ↗ “Zinc, a micronutrient, appears to have anti-viral properties with various mechanisms of action depending on the concentration” NCT04621461 ↗ “(Vitamin C, Zinc, medication for clinical symptoms such as: antipyretic agent, decongestan and mucolytic.)” NCT04810728 ↗ “containing: Lutein 12mg, Vitamin C 300mg, Zinc 10mg, Ginko Biloba 10mg, Flavonoids 25mg, Fish oil 300mg” NCT00914576 ↗ “The zinc syrup was prepared with a concentration of 7 mg zinc in each 5 ml solution.” NCT05002101 ↗ “5 mg folic acid and 30 mg elemental zinc, taken orally, daily for 6 months.” NCT01857310 ↗ “Oral Azithromycin , Cetirizine, Paracetamol, Zinc, Vitamin C, Vitamin D” NCT04935515 ↗ “Intervention Name: Zinc sulfate Other Intervention Names: Zinc” NCT06482034 ↗ “different levels of folic acid, Vitamin B12, iron and zinc” NCT00394862 ↗ “Group 1 receiving zinc and probiotic supplementation” NCT06588036 ↗ “zinc sulfate 220 mg per day orally for 6 weeks” NCT01101217 ↗ “Zinc 75mg tablet once daily for two weeks” NCT05930002 ↗ “early enteral zinc supplementation” NCT07538999 ↗ “zinc 50 mg orally daily” NCT05104424 ↗ “Zinc 75-125 mg/day” NCT04591600 ↗ “zinc 17.4mg” NCT00431691 ↗ “zinc 60 mg” NCT00963131 ↗ “30 mg zinc” NCT01437826 ↗ |
| Known as | zinc acetate | “In this study, the authors used zinc acetate to treat Japanese patients with Wilson disease and investigated its efficacy.” PMID 21078496 ↗ Sep 2010 |
| Known as | Zinc Acetate Dihydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06412653 ↗ |
| Known as | zinc chloride | “0.454% Stannous Fluoride, 0.3% Zinc Chloride,1% Alumina toothpaste containing 1100 parts per million (ppm) fluoride.” NCT06602466 ↗2“Toothpaste containing 0.454% SnF2, 0.3% zinc chloride (ZnCl2) and 1% alumina.” NCT07169188 ↗ “15 ml 0,10% cymenol + 0,10% zinc chloride, one minute rinse” NCT05543603 ↗ |
| Known as | Zinc citrate | “Compounded capsules containing each zinc citrate, green tea extract, and ascorbic acid.” NCT04898023 ↗4“Commercial Fluoridated toothpaste for gingivitis with zinc citrate.” NCT05463484 ↗ “Drug: Zinc citrate” NCT07140874 ↗ “0.5% zinc citrate” NCT07398378 ↗ |
| Known as | Zinc Phosphate | “A commercially available fluoride toothpaste containing 8% arginine + Zinc Phosphate” NCT07664592 ↗ |
| Known as | Zinc Sulfate, generic | “Zinc Sulfate, generic” NCT01809132 ↗ |
| Known as | zinc sulphate | “SM Fibro (Alpha lipoic acid 50mg, Beta-carotene 10mg, Elemental copper 1mg, Elemental selenium 75mcg, Lycopene 5mg, Vitamin E 10 IU, Zinc sulphate 27.45mg in form of the...” NCT02714543 ↗14“second group (n = 27) was on OHA and in addition 50 mg elemental zinc as zinc sulphate supplementation for 12 weeks” PMID 24082728 ↗ Jul 2013 “The 25 supplemented children had received an oral dose of 10 mg of zinc sulphate per day for 14 days” NCT04574544 ↗ “Zinc sulphate 125mg, day 2 to day 15” NCT01475227 ↗ “Drug: Zinc (zinc sulphate)” NCT00347386 ↗ “Zinc (zinc sulphate)” NCT00252304 ↗ “Zinc (zinc sulphate)” NCT07145268 ↗ “Drug: zinc sulphate” NCT06869798 ↗ “Zinc sulphate 50 mg” NCT05465434 ↗ |
| Known as | Zn SO4 | “Zinc Sulfate (Zn SO4) one tablet daily at bedtime which provides 50 mg elemental zinc (220 mg Zn SO4)” NCT01474486 ↗ |
| Known as | Zn sulfate | “Neonates will receive oral Zn sulfate solution in either low doses (10 mg/day) or high doses (20 mg/day) given twice daily.” NCT06517862 ↗ |
| Known as | ZnCl2 | “0.454 percent (%) Stannous Fluoride (SnF2), 0.3% Zinc Chloride (ZnCl2) and 1% Alumina” NCT06602466 ↗1“Toothpaste containing 0.454% SnF2, 0.3% zinc chloride (ZnCl2) and 1% alumina.” NCT07169188 ↗ |
| Action | Activate | “MTT is an endogenous antioxidant that can be induced by both zinc (Zn) and ischemia.” PMID 28302075 ↗ Mar 2017 |
| Modality | Other / unclassified | “micronutrients (especially of zinc and iron)” PMID 20730057 ↗ Aug 2010 |
| Route | Oral | “They will be instructed to take 1 mL of the solution twice daily for two months.” NCT00104494 ↗ |